| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $55.6M | +5.9% |
| Cost of Revenue | $22.5M | -2.4% |
| Gross Profit | $33.1M | +12.4% |
| R&D Expense | $5.4M | +10.5% |
| SG&A Expense | $41.4M | -12.8% |
| Operating Income | -$13.6M | +40.3% |
| Income Tax | $12K | -63.6% |
| Net Income | -$15.1M | +36.2% |
| EPS (Basic) | -$0.83 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.0M | -39.6% |
| Accounts Receivable | $7.8M | +19.6% |
| Current Assets | $36.5M | -23.8% |
| Total Assets | $44.7M | -21.5% |
| Current Liabilities | $13.5M | +13.5% |
| Long-term Debt | $20.2M | +3.8% |
| Total Liabilities | $35.1M | +2.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.3M | +8.2% |
| Capital Expenditures | $515K | -37.8% |
| Investing Cash Flow | -$515K | +35.9% |
| Financing Cash Flow | -$663K | +93.8% |
| Free Cash Flow | -$13.8M | +9.8% |
| +38.1% |
| EPS (Diluted) | -$0.83 | +38.1% |
| Stockholders' Equity |
| $9.5M |
| -58.0% |